Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [757]

Developing a vaccine for the Epstein-Barr Virus could prevent up to 200,000 cancers globally, say experts

Developing a vaccine for the Epstein-Barr Virus could prevent up to 200,000 cancers globally, say experts

Personalised tumour vaccines improve interleukin-2 treated metastatic melanoma

Personalised tumour vaccines improve interleukin-2 treated metastatic melanoma

Phase II trial of bevacizumab in locally advanced cervical cancer 'promising'

Phase II trial of bevacizumab in locally advanced cervical cancer 'promising'

ASCO GI: Study identifies a promising vaccine combination for patients with metastatic cancer of the pancreas

ASCO GI: Study identifies a promising vaccine combination for patients with metastatic cancer of the pancreas

Effectiveness of the quadrivalent human papilloma virus vaccine

Effectiveness of the quadrivalent human papilloma virus vaccine

Recurrent ovarian cancers respond to cancer vaccine after “reprogramming” with decitabine

Recurrent ovarian cancers respond to cancer vaccine after “reprogramming” with decitabine

Vaccine potential as prostate cancer protein unlocked

Vaccine potential as prostate cancer protein unlocked

One dose of HPV vaccine may be enough to prevent cervical cancer

One dose of HPV vaccine may be enough to prevent cervical cancer

Highlights from day one of the NCRI Cancer Conference 2013

Highlights from day one of the NCRI Cancer Conference 2013

Primary HPV screening provides 60–70% greater protection against invasive cervical cancer than cytology-based screening

Primary HPV screening provides 60–70% greater protection against invasive cervical cancer than cytology-based...

More from ecancer